Early rhythm control in patients with acute decompensated heart failure: results from the CYCLE cohort study

Rapid CommunicationAtrial fibrillation (AF) is common in patients with acute decompensated heart failure (HF).Both conditions share risk factors, e.g.hypertension, diabetes, coronary artery disease, and aggravate each other. 1 AF increases the risk of stroke, HF hospitalization, and mortality in acute decompensated HF. 2 Rhythm control in this population remains challenging due to frequent recurrences and limited therapeutic options.Early rhythm control reduces a composite outcome of cardiovascular death, stroke, or HF hospitalization by 21% compared with usual care in patients with AF and comorbidities, with consistent results in patients with AF and HF. 3,4 hile recent analyses indicate potential early benefits of rhythm control, the last randomized trial testing rhythm control in acute decompensated HF, ANDROMEDA, was halted nearly 20

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2025-12-01
DOI
https://doi.org/10.1093/europace/euaf314
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early rhythm control in patients with acute decompensated heart failure: results from the CYCLE cohort study

Gianluigi Savarese, Christina Magnussen, Stefan Blankenberg, Lisa Besch et al.
EP Europace
Heart Failure Treatment and Management
article

Early rhythm control in patients with acute decompensated heart failure: results from the CYCLE cohort study

Gianluigi Savarese, Christina Magnussen, Stefan Blankenberg, Lisa Besch, Caroline Kellner, Benedikt Schrage, Paulus Kirchhof, Nina Becher, Benedikt N. Beer, Jonas Sundermeyer, Marvin Kriz, Angela Dettling, Maria Luisa Benesch Vidal, Peter Moritz Becher
article en

Abstract

Rapid CommunicationAtrial fibrillation (AF) is common in patients with acute decompensated heart failure (HF).Both conditions share risk factors, e.g.hypertension, diabetes, coronary artery disease, and aggravate each other. 1 AF increases the risk of stroke, HF hospitalization, and mortality in acute decompensated HF. 2 Rhythm control in this population remains challenging due to frequent recurrences and limited therapeutic options.Early rhythm control reduces a composite outcome of cardiovascular death, stroke, or HF hospitalization by 21% compared with usual care in patients with AF and comorbidities, with consistent results in patients with AF and HF. 3,4 hile recent analyses indicate potential early benefits of rhythm control, the last randomized trial testing rhythm control in acute decompensated HF, ANDROMEDA, was halted nearly 20

EP EuropaceVol. 27(12)
Tufts Medical Center (US), Universität Hamburg (DE), Danderyds sjukhus (SE), Karolinska Institutet (SE), Stockholm South General Hospital (SE), University Medical Center Hamburg-Eppendorf (DE), German Centre for Cardiovascular Research (DE), University of Birmingham (GB)
Openalex Percentile: Top 44%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.